EC Number |
Inhibitors |
Structure |
---|
3.1.4.11 | (1 -[6-[[17-beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino] hexyl]-1H-pyrrole-2,5-dione) |
- |
|
3.1.4.11 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid |
- |
|
3.1.4.11 | 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
significant inhibition of PLC-beta with IC50: 0.006 mM, little effect on PLC-beta1, PLC-beta3, or PLC-beta4 |
|
3.1.4.11 | 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
U-73122 |
|
3.1.4.11 | 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
U73122, also inhibits Ca2+-induced inactivation of TRPV6 |
|
3.1.4.11 | 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine |
potent inhibitor |
|
3.1.4.11 | 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine |
histamine-induced elevation of plasma noradrenaline and adrenaline is dose-dependently reduced by ET-18-OCH3 |
|
3.1.4.11 | 3beta,27-dihydroxyurs-12-en-28-oic acid |
- |
|
3.1.4.11 | 3beta,7'-diacetoxy-27- 4-(E)-coumaroyloxyurs-12-en-28-oic acid |
- |
|
3.1.4.11 | 3beta-4-(E)-coumaroyloxyurs-12-en-28-oic acid |
- |
|